In a previously reported study, a patient with a parathyroid adenoma, who had not achieved clinical remission following resection of the adenoma (11), was started on a CaSR agonist that subsequently alleviated the clinical symptoms. This evidence concerns the gene CASR and parathyroid gland adenoma.